End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.23 CNY | +2.34% | +12.51% | +24.92% |
Jul. 12 | Shyndec Pharma Unit Gets Rights for Ceftazidime Avibactam Sodium for Injection | MT |
Jul. 09 | Shanghai Shyndec Pharmaceutical Obtains Drug Registration for Anti-Tumor Injection; Shares Jump 9% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.92% | 2.26B | |
+7.04% | 73.13B | |
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B | |
-1.11% | 1.57B |
- Stock Market
- Equities
- 600420 Stock
- News Shanghai Shyndec Pharmaceutical Co., Ltd.
- Shyndec Pharma Unit Gets Rights for Ceftazidime Avibactam Sodium for Injection